Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin)

Chest. 1998 Jul;114(1 Suppl):80S-82S. doi: 10.1378/chest.114.1_supplement.80s.

Authors

M Humbert¹, O Sanchez, M Fartoukh, J L Jagot, O Sitbon, G Simonneau

Affiliation

¹ Service de Pneumologie et Réanimation Respiratoire, Hôpital Antoine Béclère, Clamart, France.

PMID: 9676646
DOI: 10.1378/chest.114.1_supplement.80s

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antihypertensive Agents / administration & dosage
Antihypertensive Agents / therapeutic use*
Connective Tissue Diseases / complications*
Connective Tissue Diseases / physiopathology
Epoprostenol / administration & dosage
Epoprostenol / therapeutic use*
Hemodynamics / drug effects
Humans
Hypertension, Pulmonary / etiology
Hypertension, Pulmonary / physiopathology*
Infusions, Intravenous

Substances

Antihypertensive Agents
Epoprostenol